Use of Procalcitonin for the Diagnosis of Pneumonia in Patients Presenting with a Chief Complaint of Dyspnoea: Results from the BACH (Biomarkers in Acute Heart Failure) Trial

S. Maisel, Alan; Neath, Sean‐Xavier; W. Landsberg, Judd; Mueller, Christian; M. Nowak, Richard; Frank Peacock, W.; Ponikowski, Piotr; Möckel, Martin; J. Hogan, Christopher; H.B. Wu, Alan; Richards, Mark; Clopton, Paul; Filippatos, Gerasimos; Di Somma, Salvatore; S. Anand, Inder; L. Ng, Leong; B. Daniels, Lori; H. Christenson, Robert; Potocki, Mihael; McCord, James; Terracciano, Garret; Hartmann, Oliver; Bergmann, Andreas; G. Morgenthaler, Nils; D. Anker, Stefan

doi:10.1093/eurjhf/hfr177

Public

Use of Procalcitonin for the Diagnosis of Pneumonia in Patients Presenting with a Chief Complaint of Dyspnoea: Results from the BACH (Biomarkers in Acute Heart Failure) Trial

Published in European Journal of Heart Failure • Feb 2, 2012

Authors:

Alan S. Maisel

Sean‐Xavier Neath

Judd W. Landsberg

Abstract

AIMS: Biomarkers have proven their ability in the evaluation of cardiopulmonary diseases. We investigated the utility of concentrations of the biomarker procalcitonin (PCT) alone and with clinical variables for the diagnosis of pneumonia in patients presenting to emergency departments (EDs) with a c...

Subject

Procalcitonin

Medicine

Pneumonia

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!